GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sino-Agri Leading Biosciences Co 603970.SS · CNY

Materials · Shanghai · 🇨🇳 China

Compare

9.99

-0.10%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥11.24bn

FY2016FY2025

Net income

CN¥172.5m

FY2016FY2025

Free cash flow

−CN¥79.7m

FY2016FY2025

Shareholders' equity

CN¥1.58bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥11.24bnCN¥10.60bnCN¥10.46bnCN¥11.70bnCN¥8.82bnCN¥6.64bnCN¥4.34bnCN¥3.73bnCN¥3.50bnCN¥3.40bn
Gross profitCN¥739.8mCN¥718.3mCN¥701.5mCN¥726.8mCN¥530.4mCN¥515.5mCN¥441.4mCN¥409.5mCN¥408.5mCN¥399.7m
Research and developmentCN¥66.4mCN¥66.7mCN¥65.4mCN¥45.8mCN¥37.5mCN¥34.0mCN¥30.8mCN¥12.4mCN¥3.7mCN¥1.1m
Operating incomeCN¥347.9mCN¥324.6mCN¥315.4mCN¥352.4mCN¥270.9mCN¥211.4mCN¥193.7mCN¥172.3mCN¥151.4mCN¥75.4m
Net incomeCN¥172.5mCN¥203.4mCN¥224.8mCN¥210.3mCN¥170.3mCN¥132.4mCN¥118.9mCN¥115.5mCN¥90.3mCN¥81.7m
Diluted earnings per share0.640.760.840.780.630.490.440.440.400.41

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥4.91bnCN¥5.60bnCN¥6.01bnCN¥6.24bnCN¥4.74bnCN¥4.02bnCN¥2.74bnCN¥2.58bnCN¥2.78bnCN¥2.58bn
Cash and short-term investments—CN¥1.41bnCN¥1.66bnCN¥2.93bnCN¥1.47bnCN¥1.51bnCN¥475.3mCN¥332.1mCN¥406.0mCN¥259.9m
Total liabilitiesCN¥3.18bnCN¥3.92bnCN¥4.41bnCN¥4.76bnCN¥3.46bnCN¥2.88bnCN¥1.69bnCN¥1.63bnCN¥1.92bnCN¥2.15bn
Debt—CN¥632.8mCN¥648.5mCN¥909.9mCN¥957.2mCN¥1.12bnCN¥752.6mCN¥752.5mCN¥781.5mCN¥1.21bn
Shareholders' equityCN¥1.58bnCN¥1.52bnCN¥1.44bnCN¥1.32bnCN¥1.17bnCN¥1.03bnCN¥956.1mCN¥865.3mCN¥783.2mCN¥345.1m
Shares outstanding269m269m269m269m269m269m269m264m228m202m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−CN¥78.3mCN¥307.4m−CN¥919.9mCN¥1.54bnCN¥325.4mCN¥352.1mCN¥218.9mCN¥65.7mCN¥518.8mCN¥152.2m
Capital spending−CN¥1.4m−CN¥2.2m−CN¥4.4m−CN¥3.4m−CN¥4.0m−CN¥15.0m−CN¥2.7m−CN¥9.0m−CN¥55.4m−CN¥36.8m
Free cash flow−CN¥79.7mCN¥305.2m−CN¥924.2mCN¥1.53bnCN¥321.4mCN¥337.1mCN¥216.2mCN¥56.7mCN¥463.4mCN¥115.4m
Dividends paid−CN¥143.1m−CN¥145.0m−CN¥123.4m−CN¥67.2m−CN¥57.6m−CN¥48.0m−CN¥40.0m−CN¥71.5m−CN¥95.2m−CN¥105.9m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥4.17bnCN¥2.65bnCN¥2.29bnCN¥2.21bnCN¥4.21bnCN¥2.53bnCN¥2.08bnCN¥1.98bn
Gross profitCN¥226.9mCN¥164.6mCN¥162.6mCN¥166.8mCN¥248.1mCN¥162.3mCN¥145.9mCN¥150.4m
Operating incomeCN¥138.7mCN¥91.2mCN¥54.7mCN¥17.2mCN¥136.9mCN¥78.6mCN¥51.2mCN¥23.0m
Net incomeCN¥69.2mCN¥54.9mCN¥21.3mCN¥9.1mCN¥88.2mCN¥53.9mCN¥28.3mCN¥17.0m
Diluted earnings per share0.260.200.080.030.330.200.110.06
Cash from operations———−CN¥390.0m−CN¥528.0m−CN¥644.0mCN¥702.0mCN¥226.0m
Capital spending−CN¥1.0m−CN¥1.0m——————
Total assetsCN¥6.53bnCN¥6.57bnCN¥4.91bnCN¥6.56bnCN¥6.75bnCN¥7.14bnCN¥5.60bnCN¥6.04bn
Cash and short-term investments———CN¥317.1mCN¥526.1mCN¥879.9mCN¥1.41bnCN¥860.1m
Debt———CN¥2.46bnCN¥991.4mCN¥718.5mCN¥628.5mCN¥687.5m
Shareholders' equityCN¥1.60bnCN¥1.63bnCN¥1.58bnCN¥1.55bnCN¥1.54bnCN¥1.57bnCN¥1.52bnCN¥1.49bn

Financial ratios

Data as of 21 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin6.6%6.8%6.7%6.2%6.0%7.8%—
Operating margin2.3%3.2%3.2%3.0%3.2%3.8%—
Net margin1.5%1.9%2.1%1.8%1.9%2.0%—
Return on equity10.9%13.4%15.6%16.0%14.5%12.9%—
Return on assets3.5%3.6%3.7%3.4%3.6%3.3%—
Free cash flow yield—10.5%—————
Revenue growth6.1%1.3%-10.6%32.6%32.8%52.9%—
Earnings growth-15.2%-9.5%6.9%23.5%28.6%11.4%—
Current ratio1.47x1.37x1.31x1.29x1.31x1.34x—
Debt to equity—0.41x0.44x0.68x0.80x1.10x0.46x
Equity ratio32.1%27.1%24.0%21.1%24.7%25.5%—
Interest coverage11.42x10.16x21.16x8.03x7.08x5.20x—
R&D as a share of sales0.6%0.6%0.6%0.4%0.4%0.5%—
Buybacks as a share of market value0.0%-0.0%0.0%-0.0%0.0%0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.3%11.1%13.3%
Operating income-0.4%10.5%16.5%
Net income-6.4%5.4%6.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin6.7%6.6%6.6%7.7%
Operating margin3.1%3.0%3.1%3.2%
Net margin1.7%1.8%1.9%2.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings20.018.818.426.829.430.620.821.140.8
Price to sales0.30.40.40.50.60.60.60.71.1

Dividends and splits

Per share, in the currency the company pays

Paid for 8 years. Last went ex-dividend on 12 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.320.450.450.550.250.2140.1790.149
  • 7-for-5 split · 13 Jun 2023
  • 6-for-5 split · 18 Jun 2019
  • 6-for-5 split · 12 Jun 2018

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.